INTAI Technology Corporation (4163) Fair Value & Analysis
Industrials · TW · Market cap 5.7B TWD
Fair value as of: Jun 24, 2026
Analysis
INTAI Technology Corporation (4163) currently trades at 129.50 TWD, while our model-based Fair Value estimate is 92.29 TWD — implying the stock looks roughly 28.7% overvalued today. We read business quality at 93/100 (high quality), in the Industrials sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).
About the company
INTAI Technology Corporation produces and sells medical equipment and precision fasteners. The company offers medical products for minimally invasive surgery, cardiovascular, diagnostic devices, laparotomy, advance energy medical devices, and robotic assited surgery applications. It also provides various medical implantable devices for orthopedic trauma, spine, dental, hip and knee, surgical instruments, and craniomaxillofacial trauma applications. It also provides RF microwave products for production testing solution, ate and AI testing, military, defense, emergency, and satellite data reception industries; and industrial application products. In addition, the company is involved in metal process, molding, secondary process, laser manufacturing, unique material application, and assembly. INTAI Technology Corporation was founded in 1988 and is based in Taichung, Taiwan.
Open the full interactive analysis →
Similar stocks
Frequently asked questions
Is INTAI Technology Corporation (4163) undervalued?
What is the fair value of 4163?
What is the quality score of 4163?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.